Brno

Oncology Research

Innovative clinical trials focusing on advanced cancer treatments, including studies for leukemia, prostate cancer, and gastric cancer.

Chronic Lymphocytic Leukemia
Metastatic Prostate Cancer
Esophageal Cancer
Advanced Breast Cancer

Studies evaluating novel therapeutic combinations and targeted treatments for various cancer types.

Autoimmune Conditions

Research focused on treating inflammatory disorders and autoimmune conditions, with particular emphasis on innovative therapies.

Ulcerative Colitis
Psoriatic Arthritis
Plaque Psoriasis
Multiple Sclerosis

Evaluating new biological treatments and their long-term effectiveness in managing chronic conditions.

Respiratory and Cardiovascular

Studies addressing respiratory diseases and heart conditions, focusing on prevention and treatment strategies.

Chronic Obstructive Pulmonary Disease
RSV Prevention
Heart Failure Prevention
Cardiovascular Risk Management

Testing innovative approaches to improve patient outcomes in respiratory and cardiac conditions.

Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Recruiting

1 1 1 1
Investigated diseases:
- Chronic myeloid leukaemia
Investigated drugs:
+8
Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Recruiting

1 1 1
Investigated drugs:
- Bempedoic Acid
- Obicetrapib
+1
Treatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia

Recruiting

1 1 1
Investigated drugs:
Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Recruiting

1 1 1
Investigated drugs:
- Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
+3
Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Recruiting

1 1 1
Investigated drugs:
- Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
+3
Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Recruiting

1 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
- Tezepelumab
+1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acute cardiac event Acute coronary syndrome Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myeloid leukaemia (in remission) Acute myocardial infarction Acute promyelocytic leukaemia Acute respiratory failure Alopecia areata Amyotrophic lateral sclerosis Anaemia Anaemia of chronic disease Anhedonia Ankylosing spondylitis Arteriosclerosis Asthma Atrial fibrillation Autism spectrum disorder Autoimmune haemolytic anaemia Axial spondyloarthritis B-cell lymphoma B-cell lymphoma refractory B-cell small lymphocytic lymphoma B-cell small lymphocytic lymphoma recurrent B-cell small lymphocytic lymphoma refractory B-cell type acute leukaemia Breast cancer Breast cancer metastatic Cachexia Cardiac failure Cardiac failure acute Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chorioretinitis Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic myeloid leukaemia Chronic myeloid leukaemia (in remission) Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Clear cell papillary renal cell carcinoma Clear cell renal cell carcinoma Clostridium difficile infection Coagulation factor X level Cognitive disorder Colitis ulcerative Colorectal cancer Cough COVID-19 Crohn's disease Cystic fibrosis Cystic fibrosis respiratory infection suppression Dementia Alzheimer's type Dementia of the Alzheimer's type with delusions Dementia with Lewy bodies Dermatitis atopic Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma refractory Duchenne muscular dystrophy Dyslipidaemia Endocrine ophthalmopathy Endometrial cancer Endometrial cancer metastatic Endometrial cancer recurrent Endometriosis Eosinophilic oesophagitis Ependymoma Epidermolysis bullosa Epileptic encephalopathy Epstein-Barr virus associated lymphoma Erosive oesophagitis Escherichia urinary tract infection Essential thrombocythaemia Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Gastrointestinal stromal tumour Gastrooesophageal reflux disease Generalised anxiety disorder Gout Haematological malignancy Heparin resistance Hepatitis D Hepatoblastoma Hepatocellular carcinoma HER2 positive breast cancer Hereditary haemochromatosis Herpes zoster High-grade B-cell lymphoma Hodgkin's disease Hodgkin's disease refractory Hormone receptor negative HER2 positive breast cancer Hormone receptor positive breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Hypercholesterolaemia Hypereosinophilic syndrome Hypertension Hypertriglyceridaemia Idiopathic pulmonary fibrosis Immune thrombocytopenia Indolent systemic mastocytosis Iron deficiency Juvenile idiopathic arthritis Labour induction Left ventricular dysfunction Lennox-Gastaut syndrome Lung disorder Lymphangioma Macular oedema Magnetic resonance imaging Major depression Malignant glioma Malignant lymphoid neoplasm Malignant peritoneal neoplasm Mantle cell lymphoma Mantle cell lymphoma stage II Mantle cell lymphoma stage III Mantle cell lymphoma stage IV Marginal zone lymphoma Marginal zone lymphoma refractory Medulloblastoma Metabolic dysfunction-associated liver disease Metachromatic leukodystrophy Migraine Multifocal motor neuropathy Multiple sclerosis Myasthenia gravis Myelodysplastic syndrome Myelofibrosis Myocardial infarction Myocardial ischaemia Myocarditis Myopia Neoplasm malignant Neovascular age-related macular degeneration Nephroblastoma Nephropathy Nervous system disorder Neuroblastoma Neuropathy peripheral Neurosurgery Non-Hodgkin's lymphoma Non-Hodgkin's lymphoma refractory Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Obesity Obstructive sleep apnoea syndrome Ocular myasthenia Ovarian cancer Ovarian epithelial cancer Overweight Pancreatic carcinoma Pancreatic carcinoma metastatic Paresis Paroxysmal nocturnal haemoglobinuria Partial seizures Persistent corneal epithelial defect Philadelphia positive acute lymphocytic leukaemia Plasma cell myeloma Plasma cell myeloma recurrent Plasma cell myeloma refractory Platelet aggregation Platelet aggregation inhibition Platelet aggregation test Polycythaemia vera Primary amyloidosis Primary immunodeficiency syndrome Primary mediastinal large B-cell lymphoma refractory Primary myelofibrosis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Prostate cancer metastatic Psoriasis Psoriatic arthropathy Psychotic disorder Pulmonary embolism Relapsing multiple sclerosis Renal cell carcinoma Rhabdomyosarcoma Richter's syndrome Schizoaffective disorder Schizophrenia Secondary progressive multiple sclerosis Severe myoclonic epilepsy of infancy Short-bowel syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer recurrent Spinal muscular atrophy Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Systemic lupus erythematosus T-cell type acute leukaemia Thrombocytopenia Thrombocytosis Thrombosis prophylaxis Thrombotic thrombocytopenic purpura Torticollis Trisomy 21 Type 2 diabetes mellitus Type IIa hyperlipidaemia Uveitis

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes